EDN1, endothelin 1, 1906

N. diseases: 679; N. variants: 23
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0677886
Disease: Epithelial ovarian cancer
Epithelial ovarian cancer
0.040 Biomarker disease BEFREE Collectively, our data unveil a noncanonical activation of the RhoC/ROCK pathway through the β-arr1/PDZ-RhoGEF complex as a regulator of ETAR-induced motility and metastasis, establishing ET-1 axis as a novel regulator of invadopodia protrusions through the RhoC/ROCK/LIMK/cofilin pathway during the initial steps of EOC invasion. 26522724 2016
CUI: C0677886
Disease: Epithelial ovarian cancer
Epithelial ovarian cancer
0.040 Biomarker disease BEFREE In epithelial ovarian cancer (EOC) cells, ET-1/ET(A)R axis induced vascular-endothelial growth factor (VEGF) expression through HIF-1α nuclear accumulation. 26909598 2016
CUI: C0677886
Disease: Epithelial ovarian cancer
Epithelial ovarian cancer
0.040 AlteredExpression disease BEFREE In epithelial ovarian cancer (EOC), activation of endothelin-1 (ET-1)/endothelin A receptor (ETAR) signalling is linked to many tumor promoting effects, such as proliferation, angiogenesis, invasion and metastasis. 24530737 2014
CUI: C0677886
Disease: Epithelial ovarian cancer
Epithelial ovarian cancer
0.040 Biomarker disease BEFREE Endothelin-1 (ET-1)/endothelin A receptor (ET(A)R) axis is implicated in the pathobiology of epithelial ovarian cancer (EOC) by driving tumor-promoting effects, including EMT. 21220476 2011